{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:18:08Z","timestamp":1791919088562,"version":"4.3.4"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,6,17]],"date-time":"2020-06-17T00:00:00Z","timestamp":1592352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,6,17]],"date-time":"2020-06-17T00:00:00Z","timestamp":1592352000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["Grant No. 81671235"],"award-info":[{"award-number":["Grant No. 81671235"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Drugs Ther"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s10557-020-07018-5","type":"journal-article","created":{"date-parts":[[2020,6,17]],"date-time":"2020-06-17T05:02:36Z","timestamp":1592370156000},"page":"1129-1145","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Idebenone Protects against Atherosclerosis in Apolipoprotein E-Deficient Mice Via Activation of the SIRT3-SOD2-mtROS Pathway"],"prefix":"10.1007","volume":"35","author":[{"given":"Wei","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongzhi","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqing","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuchen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengfei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanzhu","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,17]]},"reference":[{"issue":"2","key":"7018_CR1","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1177\/1074248413504994","volume":"19","author":"S Pant","year":"2014","unstructured":"Pant S, Deshmukh A, Gurumurthy GS, Pothineni NV, Watts TE, Romeo F, et al. Inflammation and atherosclerosis--revisited. J Cardiovasc Pharmacol Ther. 2014;19(2):170\u20138.","journal-title":"J Cardiovasc Pharmacol Ther"},{"issue":"3","key":"7018_CR2","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/MOL.0000000000000302","volume":"27","author":"F Schaftenaar","year":"2016","unstructured":"Schaftenaar F, Frodermann V, Kuiper J, Lutgens E. Atherosclerosis: the interplay between lipids and immune cells. Curr Opin Lipidol. 2016;27(3):209\u201315.","journal-title":"Curr Opin Lipidol"},{"issue":"4","key":"7018_CR3","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1161\/CIRCRESAHA.116.309326","volume":"120","author":"U Forstermann","year":"2017","unstructured":"Forstermann U, Xia N, Li H. Roles of vascular oxidative stress and nitric oxide in the pathogenesis of atherosclerosis. Circ Res. 2017 Feb 17;120(4):713\u201335.","journal-title":"Circ Res"},{"key":"7018_CR4","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.3389\/fimmu.2018.03155","volume":"9","author":"Y Sohrabi","year":"2019","unstructured":"Sohrabi Y, Lagache SMM, Schnack L, Godfrey R, Kahles F, Bruemmer D, et al. mTOR-dependent oxidative stress regulates oxLDL-induced trained innate immunity in human monocytes. Front Immunol. 2019;9:3155.","journal-title":"Front Immunol"},{"issue":"3","key":"7018_CR5","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1113\/JP271301","volume":"594","author":"C Vasquez-Trincado","year":"2016","unstructured":"Vasquez-Trincado C, Garcia-Carvajal I, Pennanen C, Parra V, Hill JA, Rothermel BA, et al. Mitochondrial dynamics, mitophagy and cardiovascular disease. J Physiol. 2016;594(3):509\u201325.","journal-title":"J Physiol"},{"issue":"9","key":"7018_CR6","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.tem.2014.06.008","volume":"25","author":"EP Yu","year":"2014","unstructured":"Yu EP, Bennett MR. Mitochondrial DNA damage and atherosclerosis. Trends Endocrinol Metab. 2014;25(9):481\u20137.","journal-title":"Trends Endocrinol Metab"},{"issue":"11","key":"7018_CR7","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s11883-017-0678-6","volume":"19","author":"AJ Kattoor","year":"2017","unstructured":"Kattoor AJ, Pothineni NVK, Palagiri D, Mehta JL. Oxidative stress in atherosclerosis. Curr Atheroscler Rep. 2017;19(11):42.","journal-title":"Curr Atheroscler Rep"},{"issue":"2","key":"7018_CR8","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/dmrr.2558","volume":"31","author":"R Singh","year":"2015","unstructured":"Singh R, Devi S, Gollen R. Role of free radical in atherosclerosis, diabetes and dyslipidaemia: larger-than-life. Diabetes Metab Res Rev. 2015;31(2):113\u201326.","journal-title":"Diabetes Metab Res Rev"},{"issue":"5","key":"7018_CR9","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.cellsig.2012.01.008","volume":"24","author":"PD Ray","year":"2012","unstructured":"Ray PD, Huang BW, Tsuji Y. Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling. Cell Signal. 2012;24(5):981\u201390.","journal-title":"Cell Signal"},{"issue":"5","key":"7018_CR10","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/1873-3468.12902","volume":"592","author":"R Stefanatos","year":"2018","unstructured":"Stefanatos R, Sanz A. The role of mitochondrial ROS in the aging brain. FEBS Lett. 2018;592(5):743\u201358.","journal-title":"FEBS Lett"},{"issue":"3","key":"7018_CR11","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.celrep.2016.09.008","volume":"17","author":"J Van den Bossche","year":"2016","unstructured":"Van den Bossche J, Baardman J, Otto NA, van der Velden S, Neele AE, van den Berg SM, et al. Mitochondrial dysfunction prevents repolarization of inflammatory macrophages. Cell Rep. 2016;17(3):684\u201396.","journal-title":"Cell Rep"},{"key":"7018_CR12","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.freeradbiomed.2017.04.363","volume":"111","author":"M Xiao","year":"2017","unstructured":"Xiao M, Zhong H, Xia L, Tao Y, Yin H. Pathophysiology of mitochondrial lipid oxidation: role of 4-hydroxynonenal (4-HNE) and other bioactive lipids in mitochondria. Free Radic Biol Med. 2017;111:316\u201327.","journal-title":"Free Radic Biol Med"},{"issue":"2","key":"7018_CR13","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1080\/07853890.2017.1417631","volume":"50","author":"DA Chistiakov","year":"2018","unstructured":"Chistiakov DA, Shkurat TP, Melnichenko AA, Grechko AV, Orekhov AN. The role of mitochondrial dysfunction in cardiovascular disease: a brief review. Ann Med. 2018;50(2):121\u20137.","journal-title":"Ann Med"},{"key":"7018_CR14","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.redox.2018.09.025","volume":"20","author":"T Yuan","year":"2019","unstructured":"Yuan T, Yang T, Chen H, Fu D, Hu Y, Wang J, et al. New insights into oxidative stress and inflammation during diabetes mellitus-accelerated atherosclerosis. Redox Biol. 2019;20:247\u201360.","journal-title":"Redox Biol"},{"key":"7018_CR15","doi-asserted-by":"crossref","first-page":"923","DOI":"10.3389\/fimmu.2017.00923","volume":"8","author":"JH Tabares-Guevara","year":"2017","unstructured":"Tabares-Guevara JH, Lara-Guzm\u00e1n OJ, Londo\u00f1o-Londo\u00f1o JA, Sierra JA, Le\u00f3n-Varela YM, \u00c1lvarez-Quintero RM. Natural biflavonoids modulate macrophage-oxidized LDL interaction in vitro and promote atheroprotection in vivo. Front Immunol. 2017;8:923.","journal-title":"Front Immunol"},{"key":"7018_CR16","doi-asserted-by":"crossref","unstructured":"Montenegro L, Modica MN, Salerno L, Panico AM, Crasci L, Puglisi G, et al. In vitro antioxidant activity of Idebenone derivative-loaded solid lipid nanoparticles. Molecules. 2017;22(6).","DOI":"10.3390\/molecules22060887"},{"issue":"1\u20132","key":"7018_CR17","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s10863-014-9571-y","volume":"47","author":"S Jaber","year":"2015","unstructured":"Jaber S, Polster BM. Idebenone and neuroprotection: antioxidant, pro-oxidant, or electron carrier? J Bioenerg Biomembr. 2015;47(1\u20132):111\u20138.","journal-title":"J Bioenerg Biomembr"},{"issue":"3","key":"7018_CR18","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.bbrc.2015.08.058","volume":"465","author":"P Lin","year":"2015","unstructured":"Lin P, Liu J, Ren M, Ji K, Li L, Zhang B, et al. Idebenone protects against oxidized low density lipoprotein induced mitochondrial dysfunction in vascular endothelial cells via GSK3beta\/beta-catenin signalling pathways. Biochem Biophys Res Commun. 2015;465(3):548\u201355.","journal-title":"Biochem Biophys Res Commun"},{"key":"7018_CR19","doi-asserted-by":"crossref","first-page":"108767","DOI":"10.1016\/j.biopha.2019.108767","volume":"113","author":"J Ma","year":"2019","unstructured":"Ma J, Qiao L, Meng L, Ma L, Zhao Y, Liu X, et al. Tongxinluo may stabilize atherosclerotic plaque via multiple mechanisms scanning by genechip. Biomed Pharmacother. 2019;113:108767.","journal-title":"Biomed Pharmacother"},{"key":"7018_CR20","doi-asserted-by":"crossref","unstructured":"Chen ML, Zhu XH, Ran L, Lang HD, Yi L, Mi MT. Trimethylamine-N-oxide induces vascular inflammation by activating the NLRP3 Inflammasome through the SIRT3-SOD2-mtROS signaling pathway. J Am Heart Assoc. 2017;6(9).","DOI":"10.1161\/JAHA.117.006347"},{"issue":"3","key":"7018_CR21","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1152\/physrev.00026.2013","volume":"94","author":"DB Zorov","year":"2014","unstructured":"Zorov DB, Juhaszova M, Sollott SJ. Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release. Physiol Rev. 2014;94(3):909\u201350.","journal-title":"Physiol Rev"},{"key":"7018_CR22","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.3389\/fimmu.2018.01605","volume":"9","author":"A Angajala","year":"2018","unstructured":"Angajala A, Lim S, Phillips JB, Kim JH, Yates C, You Z, et al. Diverse roles of mitochondria in immune responses: novel insights into Immuno-metabolism. Front Immunol. 2018;9:1605.","journal-title":"Front Immunol"},{"issue":"5","key":"7018_CR23","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1161\/01.CIR.0000023921.93743.89","volume":"106","author":"SW Ballinger","year":"2002","unstructured":"Ballinger SW, Patterson C, Knight-Lozano CA, Burow DL, Conklin CA, Hu Z, et al. Mitochondrial integrity and function in atherogenesis. Circulation. 2002;106(5):544\u20139.","journal-title":"Circulation"},{"issue":"7","key":"7018_CR24","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1161\/CIRCULATIONAHA.113.002271","volume":"128","author":"E Yu","year":"2013","unstructured":"Yu E, Calvert PA, Mercer JR, Harrison J, Baker L, Figg NL, et al. Mitochondrial DNA damage can promote atherosclerosis independently of reactive oxygen species through effects on smooth muscle cells and monocytes and correlates with higher-risk plaques in humans. Circulation. 2013;128(7):702\u201312.","journal-title":"Circulation"},{"issue":"1","key":"7018_CR25","doi-asserted-by":"crossref","first-page":"54","DOI":"10.2174\/157489010790192601","volume":"5","author":"S Subramanian","year":"2010","unstructured":"Subramanian S, Kalyanaraman B, Migrino RQ. Mitochondrially targeted antioxidants for the treatment of cardiovascular diseases. Recent Pat Cardiovasc Drug Discov. 2010;5(1):54\u201365.","journal-title":"Recent Pat Cardiovasc Drug Discov"},{"key":"7018_CR26","doi-asserted-by":"crossref","unstructured":"Tiefenbach J, Magomedova L, Liu J, Reunov AA, Tsai R, Eappen NS, Jockusch RA, Nislow C, Cummins CL, Krause HM. Idebenone and coenzyme Q10 are novel PPARalpha\/gamma ligands, with potential for treatment of fatty liver diseases. Dis Model Mech 2018;11(9).","DOI":"10.1242\/dmm.034801"},{"key":"7018_CR27","doi-asserted-by":"crossref","first-page":"529","DOI":"10.3389\/fncel.2018.00529","volume":"12","author":"A Yan","year":"2018","unstructured":"Yan A, Liu Z, Song L, Wang X, Zhang Y, Wu N, et al. Idebenone alleviates Neuroinflammation and modulates microglial polarization in LPS-stimulated BV2 cells and MPTP-induced Parkinson's disease mice. Front Cell Neurosci. 2018;12:529.","journal-title":"Front Cell Neurosci"},{"issue":"11","key":"7018_CR28","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1517\/17425255.2010.530656","volume":"6","author":"C Becker","year":"2010","unstructured":"Becker C, Bray-French K, Drewe J. Pharmacokinetic evaluation of idebenone. Expert Opin Drug Metab Toxicol. 2010;6(11):1437\u201344.","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"1\u20132","key":"7018_CR29","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0891-5849(98)00205-6","volume":"26","author":"SM Cardoso","year":"1999","unstructured":"Cardoso SM, Pereira C, Oliveira R. Mitochondrial function is differentially affected upon oxidative stress. Free Radic Biol Med. 1999;26(1\u20132):3\u201313.","journal-title":"Free Radic Biol Med"},{"issue":"9","key":"7018_CR30","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.bbabio.2018.04.006","volume":"1859","author":"V Giorgio","year":"2018","unstructured":"Giorgio V, Schiavone M, Galber C, Carini M, Da Ros T, Petronilli V, et al. The idebenone metabolite QS10 restores electron transfer in complex I and coenzyme Q defects. Biochim Biophys Acta Bioenerg. 2018;1859(9):901\u20138.","journal-title":"Biochim Biophys Acta Bioenerg"},{"key":"7018_CR31","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.mito.2017.01.004","volume":"36","author":"P Yu-Wai-Man","year":"2017","unstructured":"Yu-Wai-Man P, Soiferman D, Moore DG, Burte F, Saada A. Evaluating the therapeutic potential of idebenone and related quinone analogues in Leber hereditary optic neuropathy. Mitochondrion. 2017;36:36\u201342.","journal-title":"Mitochondrion"},{"issue":"6","key":"7018_CR32","first-page":"448","volume":"8","author":"T Kobayashi","year":"1985","unstructured":"Kobayashi T, Yoshida K, Mitani M, Torii H, Tanayama S. Metabolism of idebenone (CV-2619), a new cerebral metabolism improving agent: isolation and identification of metabolites in the rat and dog. Aust J Pharm. 1985;8(6):448\u201356.","journal-title":"Aust J Pharm"},{"issue":"8","key":"7018_CR33","doi-asserted-by":"crossref","first-page":"7085","DOI":"10.3390\/nu7085324","volume":"7","author":"ZR Xu","year":"2015","unstructured":"Xu ZR, Li JY, Dong XW, Tan ZJ, Wu WZ, Xie QM, et al. Apple polyphenols decrease atherosclerosis and hepatic steatosis in ApoE\u2212\/\u2212 mice through the ROS\/MAPK\/NF-\u03baB pathway. Nutrients. 2015;7(8):7085\u2013105.","journal-title":"Nutrients"},{"issue":"3","key":"7018_CR34","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1358\/dot.2016.52.3.2463564","volume":"52","author":"N Gueven","year":"2016","unstructured":"Gueven N. Idebenone for Leber's hereditary optic neuropathy. Drugs Today (Barc). 2016;52(3):173\u201381.","journal-title":"Drugs Today (Barc)"},{"issue":"4","key":"7018_CR35","doi-asserted-by":"crossref","first-page":"155932581881218","DOI":"10.1177\/1559325818812188","volume":"16","author":"LM Fadda","year":"2018","unstructured":"Fadda LM, Hagar H, Mohamed AM, Ali HM. Quercetin and Idebenone ameliorate oxidative stress, inflammation, DNA damage, and apoptosis induced by titanium dioxide nanoparticles in rat liver. Dose Response. 2018;16(4):1559325818812188.","journal-title":"Dose Response"},{"issue":"29","key":"7018_CR36","doi-asserted-by":"crossref","first-page":"12153","DOI":"10.1074\/jbc.M117.791715","volume":"292","author":"J Traba","year":"2017","unstructured":"Traba J, Geiger SS, Kwarteng-Siaw M, Han K, Ra OH, Siegel RM, et al. Prolonged fasting suppresses mitochondrial NLRP3 inflammasome assembly and activation via SIRT3-mediated activation of superoxide dismutase 2. J Biol Chem. 2017;292(29):12153\u201364.","journal-title":"J Biol Chem"},{"issue":"7","key":"7018_CR37","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1161\/CIRCRESAHA.118.312498","volume":"123","author":"AE Kane","year":"2018","unstructured":"Kane AE, Sinclair DA. Sirtuins and NAD(+) in the development and treatment of metabolic and cardiovascular diseases. Circ Res. 2018;123(7):868\u201385.","journal-title":"Circ Res"},{"key":"7018_CR38","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.atherosclerosis.2017.08.027","volume":"265","author":"B Sosnowska","year":"2017","unstructured":"Sosnowska B, Mazidi M, Penson P, Gluba-Brzozka A, Rysz J, Banach M. The sirtuin family members SIRT1, SIRT3 and SIRT6: their role in vascular biology and atherogenesis. Atherosclerosis. 2017;265:275\u201382.","journal-title":"Atherosclerosis"},{"issue":"2","key":"7018_CR39","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1080\/10715762.2018.1549732","volume":"53","author":"J Wu","year":"2019","unstructured":"Wu J, Zeng Z, Zhang W, Deng Z, Wan Y, Zhang Y, et al. Emerging role of SIRT3 in mitochondrial dysfunction and cardiovascular diseases. Free Radic Res. 2019;53(2):139\u201349.","journal-title":"Free Radic Res"},{"key":"7018_CR40","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.neuint.2017.04.012","volume":"109","author":"I Salvatori","year":"2017","unstructured":"Salvatori I, Valle C, Ferri A, Carri MT. SIRT3 and mitochondrial metabolism in neurodegenerative diseases. Neurochem Int. 2017;109:184\u201392.","journal-title":"Neurochem Int"},{"key":"7018_CR41","doi-asserted-by":"crossref","first-page":"24108","DOI":"10.1038\/srep24108","volume":"6","author":"S Karnewar","year":"2016","unstructured":"Karnewar S, Vasamsetti SB, Gopoju R, Kanugula AK, Ganji SK, Prabhakar S, et al. Mitochondria-targeted esculetin alleviates mitochondrial dysfunction by AMPK-mediated nitric oxide and SIRT3 regulation in endothelial cells: potential implications in atherosclerosis. Sci Rep. 2016;6:24108.","journal-title":"Sci Rep"},{"issue":"5","key":"7018_CR42","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1161\/CIRCRESAHA.117.310933","volume":"121","author":"AE Dikalova","year":"2017","unstructured":"Dikalova AE, Itani HA, Nazarewicz RR, McMaster WG, Flynn CR, Uzhachenko R, et al. Sirt3 impairment and SOD2 Hyperacetylation in vascular oxidative stress and hypertension. Circ Res. 2017;121(5):564\u201374.","journal-title":"Circ Res"},{"issue":"1","key":"7018_CR43","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/imr.12285","volume":"265","author":"M Haneklaus","year":"2015","unstructured":"Haneklaus M, O'Neill LA. NLRP3 at the interface of metabolism and inflammation. Immunol Rev. 2015;265(1):53\u201362.","journal-title":"Immunol Rev"},{"key":"7018_CR44","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.3389\/fimmu.2018.02305","volume":"9","author":"N Song","year":"2018","unstructured":"Song N, Li T. Regulation of NLRP3 Inflammasome by phosphorylation. Front Immunol. 2018;9:2305.","journal-title":"Front Immunol"},{"key":"7018_CR45","doi-asserted-by":"crossref","first-page":"2183026","DOI":"10.1155\/2016\/2183026","volume":"2016","author":"L Minutoli","year":"2016","unstructured":"Minutoli L, Puzzolo D, Rinaldi M, Irrera N, Marini H, Arcoraci V, et al. ROS-mediated NLRP3 Inflammasome activation in brain, heart, kidney, and testis ischemia\/reperfusion injury. Oxidative Med Cell Longev. 2016;2016:2183026.","journal-title":"Oxidative Med Cell Longev"},{"issue":"2","key":"7018_CR46","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/cmi.2015.95","volume":"13","author":"EK Jo","year":"2016","unstructured":"Jo EK, Kim JK, Shin DM, Sasakawa C. Molecular mechanisms regulating NLRP3 inflammasome activation. Cell Mol Immunol. 2016;13(2):148\u201359.","journal-title":"Cell Mol Immunol"},{"issue":"12","key":"7018_CR47","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1161\/CIRCRESAHA.118.311362","volume":"122","author":"A Grebe","year":"2018","unstructured":"Grebe A, Hoss F, Latz E. NLRP3 Inflammasome and the IL-1 pathway in atherosclerosis. Circ Res. 2018;122(12):1722\u201340.","journal-title":"Circ Res"},{"issue":"3","key":"7018_CR48","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1002\/jcp.25930","volume":"233","author":"Z Hoseini","year":"2018","unstructured":"Hoseini Z, Sepahvand F, Rashidi B, Sahebkar A, Masoudifar A, Mirzaei H. NLRP3 inflammasome: its regulation and involvement in atherosclerosis. J Cell Physiol. 2018;233(3):2116\u201332.","journal-title":"J Cell Physiol"},{"issue":"8","key":"7018_CR49","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1038\/labinvest.2017.30","volume":"97","author":"R Wang","year":"2017","unstructured":"Wang R, Wang Y, Mu N, Lou X, Li W, Chen Y, et al. Activation of NLRP3 inflammasomes contributes to hyperhomocysteinemia-aggravated inflammation and atherosclerosis in apoE-deficient mice. Lab Investig. 2017;97(8):922\u201334.","journal-title":"Lab Investig"},{"key":"7018_CR50","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.3389\/fimmu.2019.02927","volume":"10","author":"R Corr\u00eaa","year":"2020","unstructured":"Corr\u00eaa R, Silva LFF, Ribeiro DJS, Almeida RDN, Santos IO, Corr\u00eaa LH, et al. Lysophosphatidylcholine Induces NLRP3 Inflammasome-Mediated Foam Cell Formation and Pyroptosis\u2002inHuman Monocytes and Endothelial Cells. Front Immunol. 2020;10:2927.","journal-title":"Front Immunol"},{"key":"7018_CR51","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.yjmcc.2019.08.010","volume":"135","author":"JB Perry","year":"2019","unstructured":"Perry JB, Davis GN, Allen ME, Makrecka-Kuka M, Dambrova M, Grange RW, et al. Cardioprotective effects of idebenone do not involve ROS scavenging: evidence for mitochondrial complex I bypass in ischemia\/reperfusion injury. J Mol Cell Cardiol. 2019;135:160\u201371.","journal-title":"J Mol Cell Cardiol"}],"container-title":["Cardiovascular Drugs and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-020-07018-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10557-020-07018-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-020-07018-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,9]],"date-time":"2021-11-09T10:26:28Z","timestamp":1636453588000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10557-020-07018-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,17]]},"references-count":51,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["7018"],"URL":"https:\/\/doi.org\/10.1007\/s10557-020-07018-5","relation":{},"ISSN":["0920-3206","1573-7241"],"issn-type":[{"value":"0920-3206","type":"print"},{"value":"1573-7241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,17]]},"assertion":[{"value":"17 June 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"This study was approved by the Brain Science Research Institute and the Ethics Committee from Qilu Hospital of Shandong University (Jinan, China).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Statement"}},{"value":"The authors declare that there are no known conflicts of interest associated with this publication, and no significant financial support was received for this work that could have influenced its outcome.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}